ARRIVENT BIOPHARMA, INC. (AVBP) Operating cash flow 2023–2025
ARRIVENT BIOPHARMA, INC. (AVBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$160.6MFY2025 · since FY2023: -$55.8M → -$160.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.6M | -128.7% |
| FY2024 | -$70.2M | -25.7% |
| FY2023 | -$55.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice